29 completed, 19 unknown, 3 recruiting, 1 not yet recruiting. 54 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 54 | Completed 29, Unknown 19, Recruiting 3, Not yet recruiting 1, Terminated 1, Withdrawn 1 |
Follow Rabeprazole: new trials by email Literature Review of Rabeprazole trials Research Report on Rabeprazole
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effect of ZaStaprazan on Platelet Reactivity of Clopidogrel After PercuTaneous CoronAry InteRvention Zastaprazan, Rabeprazole - Chronic Coronary Syndrome | Phase 4 | Recruiting | Yonsei University | 100 | 2026-04-02 | 2026-04-24 |
| Efficacy and Safety of Keverprazan-amoxicillin Dual Therapy for Helicobacter Pylori First-line Treatment Keverprazan 10 days, Keverprazan 14 days, Rabeprazole - Helicobacter Pylori | Phase 4 | Recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 414 | 2024-02-19 | 2025-08-14 |
| Efficacy of Proton Pump Inhibitors in Cirrhotic Patients With Acute Variceal Bleeding Proton Pump Inhibitors, No Proton Pump Inhibitors - Upper Gastrointestinal Hemorrhage | Phase 4 | Not yet recruiting | West China Hospital | 672 | 2023-10-01 | 2023-09-28 |
| Efficacy of Therapy Based on Fecal Molecular Antimicrobial Susceptibility Tests for Helicobacter Pylori Infection Rabeprazole, Colloidal Bismuth Pectin Granules, Amoxicillin - Helicobacter Pylori Infection | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 855 | 2023-03-01 | 2023-05-15 |
| Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection Vonoprazan, Rabeprazole, Amoxicillin - Helicobacter Pylori Infection | Phase 4 | Unknown | Second Affiliated Hospital, Zhejiang University, School of Medicine | 393 | 2022-08-01 | 2023-02-16 |
| Efficacies of Susceptibility-guided vs Empiric Therapy for Rescue Treatment of Helicobacter Pylori Infection susceptibility-guided tailored therapy (Group A), guidelines-recommended empiric therapy (Group B) - Helicobacter Pylori Infection | Phase 4 | Recruiting | National Taiwan University Hospital | 450 | 2022-04-11 | 2026-04-15 |
| Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication Berberine, Vonoprazan, Amoxicillin - Helicobacter Pylori Infection, Chronic Gastritis | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 300 | 2021-12-01 | 2023-01-31 |
| Helicobacter Pylori Eradication and Follow-up Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 4447 | 2021-09-30 | 2021-09-30 |
| Antibiotic Combination for H. Pylori Eradication in Penicillin-allergic Patients Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 504 | 2021-08-26 | 2021-09-14 |
| Tetracycline Versus Doxycycline for HP Rescue Therapy Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 242 | 2021-08-24 | 2021-08-26 |
| PPI-amoxicillin for H. Pylori Treatment Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 732 | 2021-08-20 | 2021-08-23 |
| 14-day PCAB-based High-dose Dual Therapy and14-day PCAB-based Triple Therapy vs 14-day PPI-based Reverse Hybrid Therapy Vonoprazan and Amoxicillin, Vonoprazan, Amoxicillin and Clarithromycin, Rabeprazole, Amoxicillin, Clarithromycin and Metronidazole - Helicobacter Pylori Eradication | Phase 4 | Unknown | Kaohsiung Medical University | 906 | 2021-08-06 | 2022-01-14 |
| Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy Berberine, Amoxicillin, Rabeprazole - Dyspepsia, Chronic Gastritis | Phase 4 | Completed | Xijing Hospital of Digestive Diseases | 524 | 2021-01-07 | 2023-01-31 |
| Bismuth-Metronidazole Triple Therapy for H. Pylori First-line Treatment Rabeprazole, Bismuth potassium citrate, Metronidazole - Helicobacter Pylori Infection | Phase 4 | Unknown | Shanghai Zhongshan Hospital | 270 | 2020-12-20 | 2020-12-22 |
| A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers RABEprazole 20 Mg Oral Delayed Release Tablet, APO-Dabigatran 150mg - Atrial Fibrillation, Venous Thromboembolism | Phase 4 | Completed | Population Health Research Institute | 46 | 2020-01-03 | 2022-03-21 |
| Assesment of the Efficiency and Safety Helicobacter Pylori Therapy With or Without Saccharomyces Boulardii Saccharomyces boulardii, Placebo - Helicobacter Pylori Infection | Phase 4 | Unknown | Clinical Centre of Serbia | 200 | 2019-06-01 | 2019-06-25 |
| Efficacies of HDDT With or Without Bismuth vs Amoxicillin-metronidazole BQT for First-line H Pylori Eradication High-dose dual therapy (rabeprazole, amoxicillin), Bismuth High-dose dual therapy (rabeprazole, amoxicillin, tripotassium dicitrate bismuthate), Amoxicillin-Metronidazole Bismuth quadruple therapy - Helicobacter Pylori Infection | Phase 4 | Completed | National Taiwan University Hospital | 603 | 2019-05-30 | 2025-04-23 |
| A RCT of Triple Therapy With Proton Pump Inhibitor vs Vonoprazan for Helicobacter Pylori Gastritis Omeprazole 20mg, Esomeprazole 20mg, Rabeprazole Sodium 20mg - Helicobacter Pylori Infection | Phase 4 | Unknown | Changi General Hospital | 252 | 2019-04-16 | 2020-10-08 |
| Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days) - Helicobacter Pylori Infection | Phase 4 | Unknown | Shandong University | 60 | 2019-04-01 | 2019-03-08 |
| A Pilot Study of a 14-day Modified Sequential Therapy for Helicobacter Pylori Infection esomeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days), rabeprazole, amoxicillin, tetracycline, furazolidone (only for the first 7 days), colloidal bismuth pectin (for the second 7 days) - Helicobacter Pylori Infection | Phase 4 | Unknown | Shandong University | 120 | 2018-12-15 | 2018-12-04 |
Showing 20 of 54. Sign in to see all of them.
Gastroesophageal Reflux (11) · Esophagitis, Peptic (3) · Gastrointestinal Hemorrhage (3) · Heartburn (3) · Gastrointestinal Diseases (2) · Helicobacter Infections (2) · Stomach Neoplasms (2) · Stomach Ulcer (2) · Adenocarcinoma (1) · Atrial Fibrillation (1) · Bacterial Infections (1) · Duodenal Ulcer (1) · Dyspepsia (1) · Gastritis (1) · Liver Cirrhosis (1)
National Taiwan University Hospital (7) · Shanghai Zhongshan Hospital (5) · Second Affiliated Hospital, Zhejiang University, School of Medicine (3) · The Catholic University of Korea (3) · Xijing Hospital of Digestive Diseases (3) · GlaxoSmithKline (2) · Janssen Cilag Pharmaceutica S.A.C.I., Greece (2) · Kaohsiung Medical University Chung-Ho Memorial Hospital (2) · Neutec Ar-Ge San ve Tic A.Ş (2) · Shandong University (2) · American University of Beirut Medical Center (1) · Beijing Children's Hospital (1) · Buddhist Tzu Chi General Hospital (1) · Changi General Hospital (1) · Chong Kun Dang Pharmaceutical (1)
China (14) · Taiwan (11) · South Korea (6) · United States (5) · Egypt (2) · Turkey (Türkiye) (2) · Australia (1) · Burma (1) · Canada (1) · Indonesia (1) · Japan (1) · Lebanon (1) · Singapore (1)
Taotao Liu, MD (5) · Jyh-Chin Yang, M.D.Ph.D. (4) · Ala' I Sharara, MD (1) · ChangSeok Bang, MD, PhD (1) · Chien-Yu Lu, MD (1) · Daphne Shih Wen Ang, MD (1) · Fu-Tien Chiang, MD, Phd (1) · Hiun-Suk Chae, Professor (1) · I-Chen Wu, MD, PhD (1) · John Eikelboom, MBBS, MSc (1)
PMID 19210493, PMID 20132153, PMID 21317257, PMID 25574111, PMID 30167954, PMID 34397042, PMID 37479526, PMID 37885233, PMID 39924352, PMID 40007457, PMID 40560185